Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹1/-
Emplozin S 10 Tablet is a combination medication for the treatment of Type 2 diabetes mellitus. It combines two active ingredients: Empagliflozin (a Sodium-Glucose Cotransporter 2 [SGLT2] inhibitor) and Sitagliptin (a Dipeptidyl Peptidase-4 [DPP-4] inhibitor). Together, these medications work synergistically to help control blood glucose levels in patients who have Type 2 diabetes.
Empagliflozin works by inhibiting the SGLT2 protein in the kidneys, reducing glucose reabsorption and promoting its excretion in urine, which helps lower blood sugar levels. Sitagliptin, on the other hand, increases the levels of incretin hormones, which play a role in stimulating insulin release and inhibiting glucagon secretion in response to meals, thereby helping to control post-meal blood sugar levels.
This combination of medications provides a dual mechanism of action, allowing for more effective glycemic control, especially when diet and exercise alone do not provide adequate control. Emplozin S 10 Tablet is typically used as an adjunct to diet and exercise for the treatment of Type 2 diabetes. It is suitable for patients who require more than one medication to manage their blood sugar levels.
Common side effects include gastrointestinal issues like nausea, diarrhea, and upper respiratory tract infections. Serious side effects may include pancreatitis, kidney problems, or low blood sugar (when combined with other antidiabetic medications).
Used in the management of Type 2 diabetes mellitus in adults, alongside diet and exercise, to improve blood glucose control.
Not recommended for patients with severe kidney problems or diabetic ketoacidosis. Regular monitoring of kidney function is advised during treatment.
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
Composition : Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)
Composition : Empagliflozin (10mg) Tablet
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (12.5mg) + Metformin (500mg)
Composition : Empagliflozin (5mg) + Metformin (500mg)
Composition : Empagliflozin (25mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation